Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

TSL-225, a dipeptide inhibitor of dipeptidyl peptidase IV

July 15, 1998

Hydroxamic acid-based MMP inhibitors described by P&U

July 14, 1998

Anergen initiates clinical trials with AnergiX

July 14, 1998

Alexion initiates C5 inhibitor phase I/II clinical trial for rheumatoid arthritis

July 14, 1998

Collagenase inhibitors in the pipeline at British Biotech

July 13, 1998

Clinical trial results in RA reported for T-614

July 9, 1998

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

July 9, 1998

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...